117 related articles for article (PubMed ID: 1386320)
21. Polyvalent TXA2/PGH2 receptor antagonists with very high affinity.
Zehender H; Patscheke H
Prog Clin Biol Res; 1989; 301():561-5. PubMed ID: 2529555
[No Abstract] [Full Text] [Related]
22. Binding of a radioiodinated agonist to thromboxane A2/prostaglandin H2 (TXA2/PGH2) receptors in guinea pig lung membranes.
Mais DE; Saussy DL; Magee DE; Williams CM
Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():347-50. PubMed ID: 1825567
[No Abstract] [Full Text] [Related]
23. Labeling of human platelet plasma membrane thromboxane A2/prostaglandin H2 receptors using SQB, a novel biotinylated receptor probe.
Komiotis D; Wencel-Drake JD; Dieter JP; Lim CT; Le Breton GC
Biochem Pharmacol; 1996 Sep; 52(5):763-70. PubMed ID: 8765474
[TBL] [Abstract][Full Text] [Related]
24. Binding of thromboxane A2/prostaglandin H2 agonists to human platelets.
Halushka PV; Kochel PJ; Mais DE
Br J Pharmacol; 1987 May; 91(1):223-7. PubMed ID: 3594077
[TBL] [Abstract][Full Text] [Related]
25. Photoaffinity labelling of a thromboxane A2/prostaglandin H2 antagonist binding site in human platelets.
Mais DE; Burch RM; Oatis JE; Knapp DR; Halushka PV
Biochem Biophys Res Commun; 1986 Oct; 140(1):128-33. PubMed ID: 2946292
[TBL] [Abstract][Full Text] [Related]
26. Human erythroleukemia cells express functional thromboxane A2/prostaglandin H2 receptors.
Mayeux PR; Mais DE; Carr C; Halushka PV
J Pharmacol Exp Ther; 1989 Sep; 250(3):923-7. PubMed ID: 2528631
[TBL] [Abstract][Full Text] [Related]
27. Purification and characterization of the human platelet TXA2/PGH2 receptor.
Narumiya S; Ushikubi F; Nakajima M; Hirata M; Okuma M
Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():339-46. PubMed ID: 1825566
[No Abstract] [Full Text] [Related]
28. A common binding site for primary prostanoids in vascular smooth muscles: a definitive discrimination of the binding for thromboxane A2/prostaglandin H2 receptor agonist from its antagonist.
Hanasaki K; Arita H
Biochim Biophys Acta; 1989 Sep; 1013(1):28-35. PubMed ID: 2528990
[TBL] [Abstract][Full Text] [Related]
29. Human platelet aggregation and shape change are coupled to separate thromboxane A2-prostaglandin H2 receptors.
Dorn GW; DeJesus A
Am J Physiol; 1991 Feb; 260(2 Pt 2):H327-34. PubMed ID: 1825455
[TBL] [Abstract][Full Text] [Related]
30. Characterization of binding of a specific antagonist, [3H]-SQ 29,548, to soluble thromboxane A2/prostaglandin H2 (TP) receptors in human platelet membranes.
Monshizadegan H; Hedberg A; Webb ML
Life Sci; 1992; 51(6):431-7. PubMed ID: 1386132
[TBL] [Abstract][Full Text] [Related]
31. Subcellular localization of a thromboxane A2/prostaglandin H2 receptor antagonist binding site in human platelets.
Saussy DL; Mais DE; Baron DA; Pepkowitz SH; Halushka PV
Biochem Pharmacol; 1988 Feb; 37(4):647-54. PubMed ID: 2963640
[TBL] [Abstract][Full Text] [Related]
32. Cyclic oxidation-reduction reactions regulate thromboxane A2/prostaglandin H2 receptor number and affinity in human platelet membranes.
Dorn GW
J Biol Chem; 1990 Mar; 265(8):4240-6. PubMed ID: 2137820
[TBL] [Abstract][Full Text] [Related]
33. Ligand binding to thromboxane receptors on human platelets: correlation with biological activity.
Armstrong RA; Jones RL; Wilson NH
Br J Pharmacol; 1983 Aug; 79(4):953-64. PubMed ID: 6317122
[TBL] [Abstract][Full Text] [Related]
34. Characterization of thromboxane A2/prostaglandin H2 receptors and histamine H1 receptors in cultured guinea-pig tracheal smooth-muscle cells.
Miki I; Nonaka H; Ishii A
Biochim Biophys Acta; 1992 Oct; 1137(1):107-15. PubMed ID: 1356444
[TBL] [Abstract][Full Text] [Related]
35. Characterization of U46619 binding in unactivated, intact human platelets and determination of binding site affinities of four TXA2/PGH2 receptor antagonists (13-APA, BM 13.177, ONO 3708 and SQ 29,548).
Kattelman EJ; Venton DL; Le Breton GC
Thromb Res; 1986 Feb; 41(4):471-81. PubMed ID: 3008368
[TBL] [Abstract][Full Text] [Related]
36. Kinetic studies on stereospecific recognition by the thromboxane A2/prostaglandin H2 receptor of the antagonist, S-145.
Kishino J; Hanasaki K; Nagasaki T; Arita H
Br J Pharmacol; 1991 Aug; 103(4):1883-8. PubMed ID: 1833018
[TBL] [Abstract][Full Text] [Related]
37. Competitive antagonism at thromboxane receptors in human platelets.
Armstrong RA; Jones RL; Peesapati V; Will SG; Wilson NH
Br J Pharmacol; 1985 Mar; 84(3):595-607. PubMed ID: 2580580
[TBL] [Abstract][Full Text] [Related]
38. Characterization of thromboxane A2/prostaglandin H2 receptors of various tissues using a new radioiodinated thromboxane A2/prostaglandin H2 mimetic, I-BOP.
Morinelli TA; Naka M; Masuda A; Oatis JE; Okwu AK; Mais DE; Saussy DL; Halushka PV
Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():331-7. PubMed ID: 1825565
[No Abstract] [Full Text] [Related]
39. Photoaffinity labelling of the human platelet thromboxane A2/prostaglandin H2 (TXA2/PGH2) receptor.
Mais DE; Halushka PV
Prog Clin Biol Res; 1989; 301():303-7. PubMed ID: 2529550
[No Abstract] [Full Text] [Related]
40. 7-[(1R,2S,3S,5R)-6,6-dimethyl-3-(4- iodobenzenesulfonylamino)bicyclo[3.1.1]hept-2-yl]-5(Z)-heptenoic acid: a novel high-affinity radiolabeled antagonist for platelet thromboxane A2/prostaglandin H2 receptors.
Naka M; Mais DE; Morinelli TA; Hamanaka N; Oatis JE; Halushka PV
J Pharmacol Exp Ther; 1992 Aug; 262(2):632-7. PubMed ID: 1386885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]